Rosen, Global Investor Counsel, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHANewsfile Corp • 07/31/21
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRAC, ATHA and COINAccesswire • 07/30/21
CLASS ACTION UPDATE for ATHA, REKR and BZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersAccesswire • 07/30/21
HAGENS BERMAN Reminds Athira Pharma (ATHA) Investors of Securities Class Action and Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 07/30/21
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATHA, DIDI and QFINAccesswire • 07/29/21
ATHA ALERT: Robbins Geller Rudman & Dowd LLP Announces Opportunity for Investors with Substantial Losses to Lead the Athira Pharma, Inc. Class Action LawsuitNewsfile Corp • 07/28/21
HAGENS BERMAN, NATIONAL ATTORNEYS, Alerts Athira Pharma (ATHA) Investors to Securities Class Action and Advises Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 07/28/21
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against Athira Pharma, Inc. for Securities FraudNewsfile Corp • 07/27/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHAPRNewsWire • 07/27/21
Athira Pharma, Inc. (ATHA) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 07/26/21
Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc.Newsfile Corp • 07/25/21
HAGENS BERMAN Advises Athira Pharma (ATHA) Investors with Losses to Contact the Firm, Deadline Approaching in Securities Fraud Class ActionNewsfile Corp • 07/22/21
Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Athira Pharma, Inc. Investors of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 07/20/21
ATHA DEADLINE: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action LawsuitBusiness Wire • 07/20/21
Rosen, Leading and Longstanding Investor Counsel, Encourages Athira Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATHANewsfile Corp • 07/20/21
HAGENS BERMAN Encourages Athira Pharma (ATHA) Investors with Losses to Contact the Firm Now to Recover Losses Due to Alleged Securities FraudNewsfile Corp • 07/20/21
ATHIRA INVESTORS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff CabraserBusiness Wire • 07/20/21
Athira Pharma to Present ATH-1017 Phase 1 Translational Data at the Alzheimer's Association International Conference 2021 (AAIC)GlobeNewsWire • 07/19/21
ATHIRA SHAREHOLDERS: August 24, 2021 Filing Deadline in Class Action – Contact Lieff CabraserBusiness Wire • 07/17/21
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Class Action Lawsuits Have Been Filed Against Athira Pharma, Inc. and Encourages Investors to Contact the Firm Before August 24, 2021Business Wire • 07/16/21
ATHA SHAREHOLDER ALERT: Shareholders With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action LawsuitNewsfile Corp • 07/15/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athira Pharma (ATHA) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact Firm's Attorneys NowNewsfile Corp • 07/15/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. - ATHANewsfile Corp • 07/14/21
ATHA INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action LawsuitBusiness Wire • 07/14/21
